As of 2025-07-06, the Net Margin of Rigel Pharmaceuticals Inc (RIGL) is 9.8%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2024-12-31 | 9.8% |
2023-12-31 | -21.5% |
2022-12-31 | -48.8% |
2021-12-31 | -12% |
2020-12-31 | -27.3% |
2019-12-31 | -112.8% |
2018-12-31 | -158.4% |
2017-12-31 | -1733.3% |
2016-12-31 | -339.2% |
2015-12-31 | -178.2% |